IRIS Accounts Production v26.3.0.614 09043174 director 1.6.25 31.5.26 31.5.26 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh090431742025-05-31090431742026-05-31090431742025-06-012026-05-31090431742024-05-31090431742024-06-012025-05-31090431742025-05-3109043174ns15:EnglandWales2025-06-012026-05-3109043174ns14:PoundSterling2025-06-012026-05-3109043174ns10:Director12025-06-012026-05-3109043174ns10:PrivateLimitedCompanyLtd2025-06-012026-05-3109043174ns10:SmallEntities2025-06-012026-05-3109043174ns10:AuditExempt-NoAccountantsReport2025-06-012026-05-3109043174ns10:SmallCompaniesRegimeForDirectorsReport2025-06-012026-05-3109043174ns10:SmallCompaniesRegimeForAccounts2025-06-012026-05-3109043174ns10:FullAccounts2025-06-012026-05-310904317412025-06-012026-05-3109043174ns10:RegisteredOffice2025-06-012026-05-3109043174ns5:CurrentFinancialInstruments2026-05-3109043174ns5:CurrentFinancialInstruments2025-05-3109043174ns5:Non-currentFinancialInstruments2026-05-3109043174ns5:Non-currentFinancialInstruments2025-05-3109043174ns5:ShareCapital2026-05-3109043174ns5:ShareCapital2025-05-3109043174ns5:RetainedEarningsAccumulatedLosses2026-05-3109043174ns5:RetainedEarningsAccumulatedLosses2025-05-3109043174ns5:IntangibleAssetsOtherThanGoodwill2025-06-012026-05-3109043174ns5:IntangibleAssetsOtherThanGoodwill2025-05-3109043174ns5:IntangibleAssetsOtherThanGoodwill2026-05-3109043174ns5:IntangibleAssetsOtherThanGoodwill2025-05-3109043174ns5:LandBuildings2025-05-3109043174ns5:PlantMachinery2025-05-3109043174ns5:MotorVehicles2025-05-3109043174ns5:ComputerEquipment2025-05-3109043174ns5:LandBuildings2025-06-012026-05-3109043174ns5:PlantMachinery2025-06-012026-05-3109043174ns5:MotorVehicles2025-06-012026-05-3109043174ns5:ComputerEquipment2025-06-012026-05-3109043174ns5:LandBuildings2026-05-3109043174ns5:PlantMachinery2026-05-3109043174ns5:MotorVehicles2026-05-3109043174ns5:ComputerEquipment2026-05-3109043174ns5:LandBuildings2025-05-3109043174ns5:PlantMachinery2025-05-3109043174ns5:MotorVehicles2025-05-3109043174ns5:ComputerEquipment2025-05-3109043174ns5:WithinOneYearns5:CurrentFinancialInstruments2026-05-3109043174ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3109043174ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2026-05-3109043174ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2025-05-31
REGISTERED NUMBER: 09043174 (England and Wales)





















FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST MAY 2026

FOR

WEST BUCKLAND BLOODSTOCK LTD

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


WEST BUCKLAND BLOODSTOCK LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST MAY 2026







DIRECTOR: Mr T H Dunn





REGISTERED OFFICE: The Gallops
West Buckland
Wellington
Somerset
TA21 9LE





REGISTERED NUMBER: 09043174 (England and Wales)





ACCOUNTANTS: Aspen Waite Limited
Chartered Accountants
Rubis House
15 Friarn Street
Bridgwater
Somerset
TA6 3LH

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

BALANCE SHEET
31ST MAY 2026

31/5/26 31/5/25
Notes £    £   
FIXED ASSETS
Intangible assets 4 8,580 11,440
Tangible assets 5 4,126,988 2,717,571
4,135,568 2,729,011

CURRENT ASSETS
Stocks 3,879,500 4,487,000
Debtors 6 1,714,981 435,549
Cash at bank 133,970 173,254
5,728,451 5,095,803
CREDITORS
Amounts falling due within one year 7 (5,004,397 ) (4,151,871 )
NET CURRENT ASSETS 724,054 943,932
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,859,622

3,672,943

CREDITORS
Amounts falling due after more than one year 8 (2,626,940 ) (1,988,165 )

PROVISIONS FOR LIABILITIES (382,181 ) (500,000 )
NET ASSETS 1,850,501 1,184,778

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 1,850,401 1,184,678
1,850,501 1,184,778

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st May 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st May 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

BALANCE SHEET - continued
31ST MAY 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the director and authorised for issue on 25th September 2026 and were signed by:





Mr T H Dunn - Director


WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST MAY 2026

1. STATUTORY INFORMATION

West Buckland Bloodstock Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

INTANGIBLE ASSETS
Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Website costs: 5 years straight line

TANGIBLE FIXED ASSETS
Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Land and buildings:50 years straight line
Plant and machinery5 years straight line
Vehicles: 20% reducing balance
Office equipment:5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

STOCKS
Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow moving or defective items where appropriate.

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2026

2. ACCOUNTING POLICIES - continued

FINANCIAL INSTRUMENTS
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment. Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price. Other basic financial liabilities are measured at amortised cost.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment.

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

RESEARCH AND DEVELOPMENT
Expenditure on research and development is written off in the year in which it is incurred.


PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2026

2. ACCOUNTING POLICIES - continued

GOING CONCERN
The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 33 (2025 - 34 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1st June 2025
and 31st May 2026 14,300
AMORTISATION
At 1st June 2025 2,860
Charge for year 2,860
At 31st May 2026 5,720
NET BOOK VALUE
At 31st May 2026 8,580
At 31st May 2025 11,440

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2026

5. TANGIBLE FIXED ASSETS
Freehold Plant and Motor Computer
property machinery vehicles equipment Totals
£    £    £    £    £   
COST
At 1st June 2025 143,961 2,080,605 994,768 2,235 3,221,569
Additions 15,120 423,428 1,259,158 734 1,698,440
At 31st May 2026 159,081 2,504,033 2,253,926 2,969 4,920,009
DEPRECIATION
At 1st June 2025 16,667 302,272 184,513 546 503,998
Charge for year 3,182 204,313 81,025 503 289,023
At 31st May 2026 19,849 506,585 265,538 1,049 793,021
NET BOOK VALUE
At 31st May 2026 139,232 1,997,448 1,988,388 1,920 4,126,988
At 31st May 2025 127,294 1,778,333 810,255 1,689 2,717,571

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/26 31/5/25
£    £   
Trade debtors 1,503,012 254,170
Other debtors 43,234 13,000
Tax 157,485 100,000
VAT - 57,129
Prepayments and accrued income 11,250 11,250
1,714,981 435,549

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31/5/26 31/5/25
£    £   
Bank loans and overdrafts 610,753 470,929
Hire purchase contracts 1,413,038 1,667,363
Trade creditors 1,437,096 705,924
Social security and other taxes 87,685 106,994
VAT 18,945 -
Other creditors 15,788 30,503
Trade finance 1,406,712 1,162,875
Accrued expenses 14,380 7,283
5,004,397 4,151,871

WEST BUCKLAND BLOODSTOCK LTD (REGISTERED NUMBER: 09043174)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST MAY 2026

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31/5/26 31/5/25
£    £   
Bank loans due 1-2 years 305,223 560,785
Hire purchase contracts 2,182,955 1,289,368
Directors' loan accounts 138,762 138,012
2,626,940 1,988,165

9. RELATED PARTY DISCLOSURES

During the year the company made sales of £118,079 (2025: £111,811) and purchase of £117,467 (2025: £363,827) from an entity under the control of a member of close family of the director
At 31 May 2026, a balance of £1,000 was owed to this related party.

During the year, the company made sales of £9,770 (2025: £18,063) and purchases of £31,351 (2025: £36,006) from an entity under the control of a member of close family of the director.
At 31 May 2026, a balance of £5,044 was owed to (2025: £7,7347 due from) this related party.

During the year the company made sales of £3,756,091 (2025: £4,160,369) and purchases of £2,980,614 (2025: £1,861,485) from an entity jointly controlled by the director
At 31 May 2026, a balance of £71,092 owed to (2025: £96,328 due from) this related party.

During the year, the company made purchases of £26,278 (2025: £45,000) from an entity under the control of a member of close family of the director.

During the year, the company made sales of £19,030 (2025: £349,441 and purchases of £17,374 (2025: £151,407) from an entity under the control of a member of close family of the director.
At 31 May 2026, a balance of £390 was owed to (2025; £10,452 due from) this related party

During the year, the company made sales of £334,389 (2025; £226,086) and purchases of £12, 012 (2025; £154,650) from an entity jointly controlled by a member of close family of the director.
At 31 May 2026, a balance of £7,747 (2025, £1,740) was due from this related party.

During the year, the company made sales of £4,000 (2025; £501,000) and purchases of £4,000 (2025: £1,667) from the director.
At 31 May 2026, a balance of £138,762 (2025, £138,012) was owed to the director.

During the year, the company made sales of £746,362 (£148,800; 2025) and purchases of £334,025 (£216,000, 2025) to West Buckland Bloodstock France, a company incorporated in France and under the control of the director.
At 31 May 2026, a balance of £23,529 (2025; nil) was due from this related party.

All outstanding amounts at year end are repayable on demand and do not attract interest.
All transactions were conducted on an arm's length basis.